News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
Maxygen, Inc. Plans Staff Cuts After Forming R&D Joint Venture With Astellas Pharma Inc.
July 1, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BizJournals -- Maxygen Inc. and Japanese drug maker Astellas Pharma Inc. will start an R&D joint venture focused on protein drugs but largely spelling the beginning of the end of the Redwood City company as it is known today.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
Astellas Pharma US, Inc.
MORE ON THIS TOPIC
Job Trends
Ramping up: 3 biotechs growing their workforce after series C raises
November 19, 2026
·
4 min read
·
Angela Gabriel
Layoffs
9 biotechs will cut at least half their California workforces
November 19, 2026
·
6 min read
·
Angela Gabriel
Job Trends
8 companies hiring in North Carolina now
November 18, 2026
·
1 min read
·
Angela Gabriel
Job Trends
Cellectis could cut 70% of workforce in shift to in vivo therapies
November 13, 2026
·
2 min read
·
Angela Gabriel